CrossAmerica Partners stock: fair value
CAPLThe fair value of CrossAmerica Partners under our model is $16.68, the price is 19% above.
The fair value is an estimate from our model, not a price target.
Daily figure as of 13 Nov 2026
Valuation signal
Fairly valuedIn our model the price counts as cheap below $11.92 and expensive above $27.81 (uncertainty high, one part of the fair value is more than twice the other).
The two parts of the fair value come to $24.59 (cash-flow model) and $8.77 (industry comparison), and the gap between them shows how uncertain the estimate is.
Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $14.68, at 7.8% it would be $19.68.
Where the number comes from
Half from the cash-flow model, half from earnings times the industry P/E (7.1).
Ten-year cash-flow model from smoothed free cash flow and its past growth until it reaches 3.8%. Discounted at 8.8% (floor: government bond yield 3.8% plus 5 percentage points, since beta 0.86 times the risk premium would give less); no analyst estimates were available.
Calculate with your own assumptionsThe calculation step by step
With these figures the cash flow model arrives at $24.59 per share: free cash flow for the next ten years, each year discounted to today at 8.8%, plus the terminal value for the years after. The table explains the calculation; it is not a recommendation.
Calculation as a table
| Year | Free cash flow | Source | Discount factor | Present value (discounted at 8.8%) |
|---|---|---|---|---|
| 2026 | $56.12M | extrapolated at −5.3% | 0.9189 | $51.57M |
| 2027 | $54.68M | extrapolated at −2.6% | 0.8443 | $46.16M |
| 2028 | $54.32M | extrapolated at −0.7% | 0.7758 | $42.14M |
| 2029 | $54.7M | extrapolated at 0.7% | 0.7129 | $38.99M |
| 2030 | $55.59M | extrapolated at 1.6% | 0.6550 | $36.41M |
| 2031 | $56.87M | extrapolated at 2.3% | 0.6019 | $34.23M |
| 2032 | $58.43M | extrapolated at 2.8% | 0.5530 | $32.31M |
| 2033 | $60.23M | extrapolated at 3.1% | 0.5082 | $30.61M |
| 2034 | $62.22M | extrapolated at 3.3% | 0.4669 | $29.05M |
| 2035 | $64.37M | extrapolated at 3.5% | 0.4291 | $27.62M |
| Step | Value |
|---|---|
| Sum of present values (ten years) | $369.1M |
| Terminal value: cash flow 2035 × (1 + 3.8%) / (8.8% − 3.8%) | $1.34B |
| Present value of terminal value (× 0.4291) | $573.53M |
| Equity value (sum plus present value of terminal value) | $942.63M |
| Shares (diluted) | 38.33M |
| Value per share (equity value divided by shares) | $24.59 |
| Earnings per share, last twelve months | $1.24 |
| × 7.1 (industry P/E) | $8.77 |
| Fair value (average of both parts) | $16.68 |
The model uses free cash flow after interest, which belongs to shareholders, discounted at the cost of equity. Net debt is therefore not deducted again.
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 25 Apr 2025)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.